Janney Montgomery Scott
HRMY icon

Janney Montgomery Scott’s Harmony Biosciences HRMY Stock Holding History

Janney Montgomery Scott’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$305K Sell
10,899
-1,577
-13% -$51.7K ﹤0.01% 2370
2025
Q4 		$467K Sell
12,476
-17
-0.1% -$559 ﹤0.01% 2247
2025
Q3 		$344K Sell
12,493
-1,122
-8% -$38.7K ﹤0.01% 2407
2025
Q2 		$430K Sell
13,615
-1,299
-9% -$41.8K ﹤0.01% 2114
2025
Q1 		$495K Sell
14,914
-2,531
-15% -$90.7K ﹤0.01% 1991
2024
Q4 		$600K Buy
17,445
+1,550
+10% +$53.3K ﹤0.01% 1878
2024
Q3 		$636K Sell
15,895
-19,474
-55% -$684K ﹤0.01% 1801
2024
Q2 		$1.07M Buy
35,369
+5,395
+18% +$162K ﹤0.01% 1408
2024
Q1 		$1.01M Buy
29,974
+2,465
+9% +$79.1K ﹤0.01% 1523
2023
Q4 		$889K Buy
27,509
+6,571
+31% +$183K ﹤0.01% 1509
2023
Q3 		$686K Buy
+20,938
New +$727K ﹤0.01% 1563

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Janney Montgomery Scott's HRMY Position: Q1 2026 in Review

Janney Montgomery Scott reduced its Harmony Biosciences (HRMY) stake by 13% in Q1 2026, selling an estimated $51.7K and leaving 10,899 shares worth $305K. The position accounts for ﹤0.01% of the portfolio, ranked #2370.

Janney Montgomery Scott first reported a position in HRMY in Q3 2023 and has held it in 11 quarters since. The position peaked at $1.07M in Q2 2024. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • Janney Montgomery Scott held 10,899 shares of Harmony Biosciences worth $305K as of Q1 2026.
  • Janney Montgomery Scott sold 1,577 Harmony Biosciences shares in Q1 2026, an estimated $51.7K.
  • Harmony Biosciences made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q1 2026, its #2370 holding.
  • Janney Montgomery Scott first reported a position in Harmony Biosciences in Q3 2023 and has held it in 11 quarters since.
  • Janney Montgomery Scott's Harmony Biosciences position peaked at $1.07M in Q2 2024.
  • 309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on Janney Montgomery Scott's 13F filing for Q1 2026, filed 22 Apr 2026.